Quality enhancement research initiative in ischemic heart disease: A quality initiative from the Department of Veterans Affairs

Medical Care

Volumn 38, Issue 6 SUPPL. 1, 2000, Pages

  Every, Nathan R ^a,b   Fihn, Stephan D ^a,b   Sales, Anne E B ^a,b   Keane, Anne ^b   Ritchie, James R ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Guidelines; Ischemic heart disease; Quality of care

Indexed keywords

CAUSE OF DEATH; COST BENEFIT ANALYSIS; DOCUMENTATION; EVIDENCE BASED MEDICINE; FACTUAL DATABASE; GOVERNMENT; HEALTH SERVICES RESEARCH; HEART MUSCLE ISCHEMIA; HUMAN; METHODOLOGY; MORTALITY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; RISK FACTOR; STANDARD; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

BENCHMARKING; CAUSE OF DEATH; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; DOCUMENTATION; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; MYOCARDIAL ISCHEMIA; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; RISK FACTORS; TOTAL QUALITY MANAGEMENT; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 0034204013     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. American Heart Association. Heart and stroke facts: 1997 statistical supplement. Dallas, TX: American Heart Association; 1997.
2. Every NR, Parsons LP, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;335:1253-1260.
3. Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-1111.
4. Theroux P, Water D, Qiu S, McCans J, de Guise P, Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993;88(pt 1):2045-2048.
5. Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med 1992;327:175-181.
6. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group. Lancet 1990;336:827-830.
7. Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study: Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1987;2:871-874.
8. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither, among 17,187 cases of suspected acute myocardial infarction: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2:349-360.
9. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction: The GUSTO Investigators. N Engl J Med 1982;329:673-682.
10. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2: Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
11. From the Centers for Disease Control. Public health focus: Effectiveness of smoking-control strategies - United States. JAMA 1992;268:1645-1646.
12. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Smoking cessation: Clinical practice guideline, number 18. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996. AHCPR No. 97-0692.
13. Cohen SJ, Stookey GK, Katz BP, Drook CA, Smith DM. Encouraging primary care physicians to help smokers quit: A randomized, controlled trial. Ann Intern Med 1989;110:648-652.
14. Randomised trial of cholesterol lowering 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
15. Headrick LA, Speroff T, Pelecanos HI, Cebul RD. Efforts to improve compliance with the National Cholesterol Education Program guidelines: Results of a randomized controlled trial. Arch Intern Med 1992;152:2490-2496.
16. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996;335:1001-1009.
17. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
18. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
19. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
20. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction: The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med 1995;332:80-85.
21. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328-1428.
22. Braunwald E, Mark DB, Jones RH. Unstable angina: diagnosis and management: Clinical Practice Guideline No. 10 (amended). Rockville, MD: Agency for Health Care Policy and Research and the National Heart, Lung and Blood Institute, Public Health Service, US Department of Health and Human Services; 1994. Publication AHCPR 94-0602.
23. National Institutes of Health. Cholesterol lowering in the patient with coronary artery disease: Physician monograph. Rockville, Md; National Institutes of Health; 1997.
24. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-121.
25. Krumholz HM, Murillo JE, Chen J, Vaccarino V, Radford MJ, Ellerbeck EF, Wang Y. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997;277:1683-1688.
26. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with Heart Failure. Arch Intern Med 1997;157:2242-2247.
27. Krumholz HM, Vaccarino V, Ellerbeck EF, Kiefe C, Hennen J, Kresowik TF, Gold JA, Jencks SF, Radford MJ. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 64 years of age. Am J Cardiol 1997;79:581-586.
28. Krumholz HM, Radford MJ, Ellerbeck EF, Hennen J, Meehan TP, Petrillo M, Wang Y, Jencks SF. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med 1996;124:292-298.
29. Ellerbeck EF, Jencks Sf, Radford MJ, Kresowik TF, Craig AS, Gold JA, Kramholz HM, Vogel RA. Quality of care for Medicare patients with acute myocardial infarction: A four-state pilot study from the Cooperative Cardiovascular Project. JAMA 1995;273:1509-1514.
30. Barron HV, Bowlby LJ, Breen T, Rogers WJ, Canto JG, Zhang Y, Tiefenbrunn AJ, Weaver WD. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-1156.
31. Smith NL, Reiber GE, Psaty BM, Heckbert SR, Siscovick DS, Ritchie JL, et al. Trends in the post-hospitalization treatment of unstable angina pectoris: 1990 to 1995. Am J Cardiol 1999;84:632-638.
32. Barron HV, Viskin S, Lundstrom RJ, Swain BE, Truman AF, Wong CC, Selby JV. Beta-blocker dosages and mortality after myocardial infarction: Data from a large health maintenance organization. Arch Intern Med 1998;158:449-453.
33. Fiore MC, Jorenby DE, Schensky AE, Smith SS, Bauer RR, Baker TB. Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc 1995;70:209-213.
34. Woller SC, Smith SS, Piasecki TM, Jorenby DE, Helberg CP, Love RR, et al. Are clinicians intervening with their patients who smoke? A "real-world" assessment of 45 clinics in the upper Midwest. Wis Med J 1995;94:266-272.
35. Petersen LA, Wright SM, Brown C, Lamkin RP, Daley J. Access to medical therapies for acute myocardial infarction varies by VAMC. Presented at the 16th Annual US Department of Veterans Affairs Health Services Research and Development Meeting, Washington, DC, March 1998.
36. Rubins HB, Robins SJ, Collins D, Iranmanesh A, Wilt TJ, Mann D, et al. Distribution of lipids in 8,500 men with coronary artery disease: US Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995;75:1196-201.
37. Chen L, Every NR. Care and outcomes in acute myocardial infarction: Comparisons of VA and non-VA hospitals. Presented at the US Department of Veterans Affairs Health Services Research and Development Annual Meeting, Washington, DC, February 18-20, 1998.
38. Hammermeister KE, Johnson R, Marshall G, Grover FL. Continuous assessment and improvement in quality of care: A model from the Department of Veterans Affairs Cardiac Surgery. Ann Surg 1994;219:281-290.
39. Halpern MA. The measurement of quality of care in the Veterans Health Administration. Med Care 1996;34:MS55-MS68.
40. Hlatky MA. Understanding concepts related to health economics. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence based cardiology. London, UK: BMJ Publishing Group; 1998:76-91.
41. Recommendations of a Task Force of The European Society of Cardiology and The European Resuscitation Council for the pre-hospital management of acute heart attacks. Eur Heart J 1998;19:1140-1164.
42. American College of Physicians Guidelines for using serum cholesterol, high-density lipoprotein cholesterol and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996;124:515-517.
43. National Cholesterol Education Program Expert Panel. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Washington, DC; US Department of Health and Human Services, Public Health Service, National Institutions of Health, National Heart, Lung, and Blood Institute; 1997. Publication NIH 97-3794.
44. Weintraub WS, McKay CR, Riner RN, Ellis SG, Frommer PL, Carmichael DB, et al. The American College of Cardiology NH Database: Progress and Challenges: American College of Cardiology Database Committee. Am Coll Cardiol 1997;29:459-465.
45. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-705.
46. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423-1431.
47. Elson RB, Connelly DP. Computerized patient records in primary care: Their role in mediating guideline-driven physician behavior change. Arch Family Med 1995;4:698-705.
48. Tierney WM, Hui SL, McDonald CJ. Delayed feedback of physician performance versus immediate reminders to perform preventive care: Effects on physician compliance. Med Care 1986;24:659-666.
49. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Firm SD. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1996;74:1240-1244.
50. Kazis LE, Skinner K, Miller D, Clark J, Lee A. Quality of life in veterans: The Veterans Health Study. Presented at the Annual Meeting of Association of Health Services Research, Washington, DC, February 17-19, 1993.